Back to search
FDAFDA · Food and drugs·Recall number D-0007-2015

ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA NDC 68382-022-01

Published October 15, 2014 · Recall initiated: August 5, 2014

Summary

FDA records drug Class II recall D-0007-2015, published October 15, 2014 and initiated August 5, 2014. Recalling firm: Zydus Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 5400 bottles; Lot: MP2292 Exp. 01/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.

What to do

Voluntary: Firm initiated · Letter

Get an email if ATENOLOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATENOLOL
Manufacturer
Zydus Pharmaceuticals USA Inc
Distributor
Nationwide
Lot
MP2292 Exp. 01/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA NDC 68382-022-01 recalled?

Yes. FDA published recall D-0007-2015 on October 15, 2014. Reported hazard: Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATENOLOL.